Screener
Bicara Therapeutics BCAX Other Non-Current Assets
Other Non-Current Assets at other companies
Other financials
Where this comes from
Reported directly by Bicara Therapeutics in its filing.
Tagged under the XBRL concept us-gaap:OtherAssetsNoncurrent.
The source filing: Bicara Therapeutics’s 10-Q, filed May 11, 2026.
- Filed
- May 11, 2026, 4:03 PM EDT
- Fiscal quarter
- Q1 FY2026
- Calendar quarter
- Q1 2026
- Accession
- 0001628280-26-033429
| Line item | March 31, 2026 | December 31, 2025 |
|---|---|---|
| Total current assets | 544,915 | 422,053 |
| Property and equipment, net | 346 | 330 |
| Right of use asset – operating lease | 1,428 | 1,701 |
| Other assets | 6,910 | 6,910 |
| Total assets | $553,599 | $430,994 |
| Liabilities and stockholders’ equity | ||
| Current liabilities: | ||
| Accounts payable | $6,188 | $5,515 |
Item 1. Financial Statements (Unaudited)
FAQ
- What is Bicara Therapeutics's other non-current assets?
- Bicara Therapeutics (BCAX) reported other non-current assets of $6.91M in Q1 2026.
- How has Bicara Therapeutics's other non-current assets changed year-over-year?
- Bicara Therapeutics's other non-current assets increased by 4.1% year-over-year, from $6.64M to $6.91M.
- What is the long-term trend for Bicara Therapeutics's other non-current assets?
- Over 2 years (2023 to 2025), Bicara Therapeutics's other non-current assets has grown at a 81.7% compound annual growth rate (CAGR), from $2.09M to $6.91M.
- What does other non-current assets mean?
- Long-term assets not classified in specific categories — a catch-all for miscellaneous non-current assets.
Ask your AI about Bicara Therapeutics's other non-current assets.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude